A Virus Almost Everyone Has Is Linked to MS and Cancer

A virus that infects nearly everyone on Earth by adulthood is now tied by hard science to multiple sclerosis and at least six types of cancer.

Quick Take

A major U.S. military study found Epstein-Barr virus infection came before multiple sclerosis in 97% of cases studied, raising MS risk 32-fold.
Health agencies say Epstein-Barr virus causes six different cancers, including Hodgkin’s disease and nasopharyngeal cancer.
A 2025 global study links a common Epstein-Barr antibody to higher risk of lung cancer, liver cancer, and lymphoma.
New 2026 genetic research connects the virus to rheumatoid arthritis, lupus, and type 1 diabetes, though that link is less proven than the MS finding.
Scientists warn that broad claims calling Epstein-Barr an “everything virus” go further than the strongest evidence actually shows.

A Common Virus With Uncommonly Strong Evidence

Epstein-Barr virus infects more than 90% of adults worldwide, usually causing nothing worse than a mild childhood illness or teenage mono. For decades, scientists suspected it played a role in serious diseases later in life. That suspicion turned into strong proof in 2022, when researchers tracked more than 10 million active-duty U.S. military members over years to see who developed multiple sclerosis.

The Multiple Sclerosis Breakthrough

The study compared 801 people who developed multiple sclerosis with 1,566 matched people who did not. Nearly all the multiple sclerosis patients, 97%, had caught Epstein-Barr virus before their diagnosis. People infected with the virus faced a 32-fold higher risk of developing multiple sclerosis than people who stayed uninfected. The National Institutes of Health said the link was too strong to be explained by any other known risk factor.

Researchers at Stanford went further, finding a possible reason why. About 20% to 25% of multiple sclerosis patients carry antibodies that attack both a viral protein called EBNA1 and a brain protein called GlialCAM. That means the immune system, while fighting the virus, may accidentally start attacking the brain’s protective coating. A separate review called the 2022 findings “robust evidence” that the virus can actually cause the disease, not just appear alongside it.

Cancer Links Backed By Global Health Bodies

The virus’s reach goes beyond the brain. The World Health Organization’s cancer research arm lists Epstein-Barr virus as a proven cause of several cancers, including Burkitt’s lymphoma, Hodgkin’s disease, and nasopharyngeal cancer. The U.S. National Toxicology Program reached the same conclusion, confirming sufficient evidence that the virus causes six different cancers. A 2025 study added a new layer, tracking a common Epstein-Barr antibody across a large population and finding it linked to higher rates of lung cancer, liver cancer, and lymphoma.

Newer, Less Certain Claims About Autoimmune Disease

A 2026 study in the journal Nature examined genetic data on a population scale and found that Epstein-Barr virus activity shares genetic patterns with autoimmune diseases like rheumatoid arthritis, lupus, and type 1 diabetes. That finding is real, but it is not the same kind of proof scientists have for multiple sclerosis. The military cohort study tracked actual infection timing in real patients over years. The autoimmune disease research relies more on genetic overlap and antibody patterns, which show a connection but do not prove the virus directly causes those illnesses.

(17/62)

In the 1980s, clusters of chronic fatigue illness led to the term “chronic fatigue syndrome.”

CDC reported a Nevada cluster initially discussed in relation to chronic Epstein-Barr virus disease.

In 1988, Holmes and colleagues proposed a working case definition for…

— Manuel Ruiz (@manruipa) August 20, 2026

That gap matters because public discussion often treats every disease link the same way. Headlines calling Epstein-Barr the “everything virus” lump together strong, direct evidence for multiple sclerosis and certain cancers with weaker, more preliminary evidence for other autoimmune conditions. Scientists studying the virus have not established that it is the main cause of most autoimmune disease, only that it is a strong and proven factor in a specific set of illnesses.

Why This Matters Going Forward

Because nearly everyone carries the virus, figuring out why only some infected people get sick is genuinely hard. Researchers say the next step is running long-term studies on rheumatoid arthritis, lupus, and type 1 diabetes patients, similar to the military-based multiple sclerosis study, to see if infection timing predicts disease the same way. Drug companies are also testing whether targeting the virus directly, through vaccines or immune therapies, can prevent or treat these conditions. Until those studies finish, the strongest, most tested claims remain tied to multiple sclerosis and a defined list of cancers.